Search

Your search keyword '"Baurand, Amandine"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Baurand, Amandine" Remove constraint Author: "Baurand, Amandine" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
17 results on '"Baurand, Amandine"'

Search Results

1. Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)

2. Patient satisfaction, experience and preferences in the implementation of genetics teleconsultations in the North-eastern region of France

3. Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients

4. The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles

5. Incomplete Timothy syndrome secondary to a mosaic mutation of the CACNA1C gene diagnosed using next-generation sequencing

6. A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

7. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

8. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

9. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

10. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

11. Incomplete Timothy syndrome secondary to a mosaic mutation of the CACNA1C gene diagnosed using next‐generation sequencing

12. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

13. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

14. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene

15. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.

16. GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.

17. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?

Catalog

Books, media, physical & digital resources